Patents for C12R 1 - Micro-organisms (92,025) |
---|
06/21/2000 | EP1009765A1 EPO PRIMARY RESPONSE GENE, EPRG3Spt |
06/21/2000 | EP1009763A1 Synthetic hepatitis c genes |
06/21/2000 | EP1009443A1 priA POLYPEPTIDES |
06/21/2000 | EP0205564B2 Method for the production of erythropoietin |
06/20/2000 | US6077950 Adjusting efficiency of animals antibody response by administering animal a polypeptide to activate antibody response |
06/20/2000 | US6077935 Unglycosylated viral polypeptide; for the detection of viral antigens in human blood; for vaccine development |
06/20/2000 | US6077827 Family of peptides known as xenoxins |
06/20/2000 | US6077706 Helicobacter pylori proteins useful for vaccines and diagnostics |
06/20/2000 | US6077702 Enzymatic protein for the degradation of linked glucans; for the preparation of animal feeds |
06/20/2000 | US6077696 Recombinant production of novel polyketides |
06/20/2000 | US6077690 Dna which encodes a 54 kilodalton protein of specific amino acid sequence; for vaccines, diagnosis of infections, and recombinant production of protein |
06/20/2000 | US6077679 Herpes virus proteinase and method of assaying |
06/20/2000 | US6077676 Single-chain polypeptides comprising troponin I and troponin C |
06/20/2000 | US6077518 Cloning of mite allergens |
06/20/2000 | US6077506 Strain of bacillus for controlling plant disease |
06/20/2000 | CA2186875C Gene imparting flocculability to yeast and gene product |
06/20/2000 | CA1341030C Protein active in humoral hypercalcemia of malignancy-pthrp |
06/15/2000 | WO2000034505A1 Expression system for factor viii |
06/15/2000 | WO2000034502A1 Production of ascorbic acid using yeast |
06/15/2000 | WO2000034498A1 Two-step immunization procedure against chlamydia infection |
06/15/2000 | WO2000034484A1 Polymorphic loci that differentiate escherichia coli 0157:h7 from other strains |
06/15/2000 | WO2000034483A2 Compounds and methods for treatment and diagnosis of chlamydial infection |
06/15/2000 | WO2000034481A2 DRUG TARGETS IN $i(CANDIDA ALBICANS) |
06/15/2000 | WO2000034460A1 Vectors having terminal repeat sequence of epstein-barr virus |
06/15/2000 | WO2000034454A2 Microcellular polymers as cell growth media and novel polymers |
06/15/2000 | WO2000034452A1 Glucoamylases with n-terminal extensions |
06/15/2000 | WO2000034444A2 Method and composition for preserving viruses |
06/15/2000 | WO2000034440A1 Microorganisms for improving plant productivity |
06/15/2000 | WO2000034189A1 Method for treating a waste stream using photosynthetic microorganisms |
06/15/2000 | WO2000009711A3 ISOLATED AND PURIFIED HUMAN SOLUBLE GUANYLYLCYCLASE α1/β1 (hsGCα1/β1) |
06/15/2000 | WO2000009693A3 Identification of the gene causing the mouse scurfy phenotype and its human ortholog |
06/15/2000 | WO2000009654A3 Profiling and cataloging expressed protein tags |
06/15/2000 | WO2000006726A3 Delta-related polypeptides |
06/15/2000 | WO2000006718A3 Expression of functional eukaryotic proteins |
06/15/2000 | WO2000005378A3 Streptococcus suis vaccines and diagnostic tests |
06/15/2000 | WO2000005369A3 Nucleotide sequences and amino acid sequences of secreted proteins involved in angiogenesis |
06/15/2000 | WO1999014328A3 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
06/15/2000 | CA2746535A1 Compounds and methods for treatment and diagnosis of chlamydial infection |
06/15/2000 | CA2354264A1 Microorganisms for improving plant productivity |
06/15/2000 | CA2354232A1 Compounds and methods for treatment and diagnosis of chlamydial infection |
06/15/2000 | CA2353525A1 Drug targets in candida albicans |
06/15/2000 | CA2352534A1 Polymorphic loci that differentiate escherichia coli 0157:h7 from other strains |
06/15/2000 | CA2352046A1 Glucoamylases with n-terminal extensions |
06/15/2000 | CA2351890A1 Method and composition for preserving viruses |
06/14/2000 | EP1007743A2 Enzymes mixture |
06/14/2000 | EP1007724A1 Cryptosporidium detection method |
06/14/2000 | EP1007722A1 Cold-active protease cp-58 and psychrotrophic bacteria |
06/14/2000 | EP1007718A1 Polymerase enhancing factor (pef) extracts, pef protein complexes, isolated pef protein, and methods for purifying and identifying |
06/14/2000 | EP1007711A1 Für drosomycin kodierendes chimäres gen, dieses gen enhaltender vektor und herstellung von krankheitsresistenten transgenen pflanze |
06/14/2000 | EP1007681A1 Method of increasing the iron content of plant cells |
06/14/2000 | EP1007655A1 Rnase l activators and antisense oligonucleotides effective to treat rsv infections |
06/14/2000 | EP1007646A1 Protease variants and compositions |
06/14/2000 | EP1007625A1 Immunity enhancing lactic acid bacteria |
06/14/2000 | EP1007624A1 Ds11 (kctc 0231bp), novel bacillus sp. strain and novel phytase produced by it |
06/14/2000 | EP1007550A2 COMPOUNDS AND METHODS FOR THE DIAGNOSIS AND TREATMENT OF $i(EHRLICHIA) INFECTION |
06/14/2000 | EP1007537A1 Receptor protein designated 2f1 |
06/14/2000 | EP1006796A1 Compositions and methods for administering borrelia dna |
06/14/2000 | EP1006783A1 Shoot meristem specific promoter sequences |
06/14/2000 | EP1006782A1 Polypeptides fused with alfalfa mosaic virus or ilarvirus capsid |
06/14/2000 | EP0668246B1 Process using the strains of Acinetobacter species (Bicoccum), Arthrobacter species and Rhodococcus species for the biological treatment of oil pollution |
06/14/2000 | CN1256712A Plant pest control |
06/14/2000 | CN1256625A Topical application of enzymes using peelable film |
06/14/2000 | CN1256314A Fermentation process for preparing D-pantothenic acid by amplifying PAND gene in microbe |
06/14/2000 | CN1256313A Method for fermentation production of D-pantothenic acid using corynebacteria |
06/14/2000 | CN1256310A Process for preparing fowl paralysis virus using continuous avian cell line |
06/14/2000 | CN1256308A Plasmid and carrier from glucose Bacillus bacteria |
06/14/2000 | CN1053472C Oligonucleotides derived from the SOD family |
06/14/2000 | CN1053469C Production of gamma linolenic acid by delta 6-desaturase |
06/14/2000 | CN1053447C Enzymatic acylation of 3-hydroxymethyl cephalosporins |
06/14/2000 | CN1053446C Novel thiomarinol derivatives and their prepn. |
06/13/2000 | US6075128 Materials and methods for isolating IgA immunoglobulins |
06/13/2000 | US6075119 Particles useful in the prevention and treatment of staphylococcal or streptococcal infection |
06/13/2000 | US6075008 Method for promoting cell proliferation and growth |
06/13/2000 | US6074875 Materials and methods relating to the regulation of polypeptide production in cells |
06/13/2000 | US6074867 Degrading carboxymethylcellulose comprising contacting a sample containing carboxymethylcellulose with enzyme with cellulase activity |
06/13/2000 | US6074866 Shuttle vectors for the introduction of DNA into mycobacteria and utilization of such bacteria as vaccines |
06/13/2000 | US6074863 Hydrolytic enzyme for the treatment of paper products or use as a detergent enzyme |
06/13/2000 | US6074857 Efficient commercial large scale production by culturing a strain of trichosporonoides oedocephalis in a culture medium containing 20 to 50 weight per volume of saccharides and recovering accumulated product |
06/13/2000 | US6074855 Fermenting a culture of a fungus selected from sporotrichum or phanerochaete species and isolating antibiotic compound; bactericides against helicobacter; antiulcer agents |
06/13/2000 | US6074854 Pullulanase, microorganisms which produce it, processes for the preparation of this pullulanese and the uses thereof |
06/13/2000 | US6074848 Amino acid sequence; for antiproliferative and wound healing agents |
06/13/2000 | US6074839 Transforming growth factor αHI |
06/13/2000 | US6074836 Method of marking eukaryotic cells |
06/13/2000 | US6074826 Nucleic acid amplification oligonucleotides and probes to Lyme disease associated Borrelia |
06/13/2000 | US6074820 Detection and differentiation of mycobacterium tuberculosis complex bacteria by direct variant repeat oligotyping |
06/13/2000 | US6074649 Recombinant composition containing feline herpes virus type 1, particularly for treating feline infectious peritonitis |
06/13/2000 | US6074646 Nondenatured HIV envelope antigens for detecting early HIV-specific antibodies |
06/13/2000 | CA2159079C Methods and dna expression systems for over-expression of proteins in host cells |
06/13/2000 | CA2118309C Lymphocyte activation antigen hb15, a member of the immunoglobulin superfamily |
06/13/2000 | CA2079105C Hepatitis c virus protease |
06/13/2000 | CA2048450C Antisense oligonucleotide antibiotics complementary to the macromolecular synthesis operon, methods of treating bacterial infections and methods for identification of bacteria |
06/09/2000 | CA2289951A1 Processes for preparation of marek's disease virus using continuous avian cell lines |
06/08/2000 | WO2000032822A1 Methods for introducing heterologous cells into fish |
06/08/2000 | WO2000032772A2 Erythropoietic compounds |
06/08/2000 | WO2000032767A1 RECOMBINANT SOLUBLE Fc RECEPTORS |
06/08/2000 | WO2000032766A1 Human vanilloid receptors and their uses |
06/08/2000 | WO2000032624A2 Uncoupling protein 5 - ucp5 |
06/08/2000 | WO2000032221A2 Promotion or inhibition of angiogenesis and cardiovascularization |
06/08/2000 | WO2000032152A2 Compositions and methods for regulating bacterial pathogenesis |
06/08/2000 | WO2000032047A1 Plasmid maintenance system for antigen delivery |